In a recent turn of events, tech titan Apple suffered a setback over its patent dispute with medical technology firm Masimo. The U.S. Federal Circuit affirmed, on Friday, two additional rulings by administrative patent boards that favoured Masimo, adding to the latter’s tally of wins in a litigious saga continuing in a Californian district court.
Legal reporting states that the ongoing dispute involves Masimo’s patents, the specifics of which remain unclear as this case unfolds. This development marks a break in Apple’s stride, as it had previously managed to secure favorable rulings in earlier rounds of this dispute.
The rulings from the Federal Circuit once more throw the spotlight on the delicate and contested realm of tech and medical patents, and the legal wrangles these lead to among corporates with high stakes.